Chugai Pharmaceutical stock pre-market at EUR 36.74 on October 21, 2026
Published on 10/21/2026 at 08:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResearch, sales and results date
- Chugai researches, develops, manufactures and sells pharmaceuticals across domestic and overseas operations.
- Chugai’s investor-relations calendar lists fiscal 2026 third-quarter results for October 27, 2026, at 5:00 p.m. JST.
- Chugai Pharmaceutical stock is at EUR 36.74 at 8:30 a.m. CEST at Lang & Schwarz on October 21, 2026.
Chugai Pharmaceutical researches, develops, manufactures and sells pharmaceuticals in Japan and overseas. Chugai Pharmaceutical stock is at Lang & Schwarz at EUR 36.74 at 8:30 a.m. CEST on October 21, 2026.
Business and upcoming results
The company operates across domestic and overseas pharmaceutical businesses, covering research, development, manufacturing and sales. Chugai’s investor-relations calendar lists fiscal 2026 third-quarter results for October 27, 2026, at 5:00 p.m. JST, followed by a results conference at 6:00 p.m. JST, according to Chugai Pharmaceutical’s investor-relations site.
Ahead of the Xetra open
The bid is EUR 36.37 and the ask is EUR 37.11, a spread of 2.01 percent. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Chugai Pharmaceutical stock.
The group and its market
Chugai earns revenue by researching, developing, manufacturing and selling pharmaceutical products in its domestic and overseas businesses. The company is based in Japan, making the Nikkei 225 the relevant benchmark for its home market. Market context: Market report Nikkei 225.
